Do These Biotech Dogs Still Have Legs? - TheStreet Feb 08, 2008 · I also liked YM BioSciences because the stock was cheap, at around $2 last summer. The nimo program was risky, just moving into phase II studies, but for $2, the stock looked like a buy to me. The Big Bet on YM BioSciences | The Motley Fool At the moment, YM BioSciences isn't one of those biotechs with a clear binary event to jump in ahead of. The full data from the phase 2 trial might propel the stock forward, but investors aren't
24 Feb 2012 YM Biosciences (AMEX:YMI) is trading at unusually high volume Friday with 9.7 million shares changing hands. It is currently at 7.5 times its 6 Oct 2009 The stock-for-stock deal will also allow YM the opportunity to begin clinical trials in Australia with its oncology drug nimotuzumab, which is already
Gilead Sciences announced Wednesday that it's buying YM Biosciences for $465 million in a bid to fill out its oncology business.. YM's shares soared 78% in early trading, approaching the $2.95 a YM Biosciences Historical Data - YMI | ADVFN YM Biosciences (YMI) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. YM BioSciences (YMI) - StreetInsider.com Reports Back to YMI Stock Lookup. Pages: 1 2 »» Last Page. YM BioSciences (YMI) – StreetInsider.com Reports Feb 7, 2013 07:22 AM YM BioSciences (YMI) Posts Q2 Loss of 7c/Share. The Wait Goes On At YM Biosciences (NASDAQ:GILD) | Seeking ... Sep 04, 2012 · While I'm cautiously optimistic that YM Biosciences does have a real winner in myelofibrosis, it may well be hard for this stock to outperform without the …
Gilead Sciences, Inc. Completes Acquisition of YM BioSciences Feb 11, 2013 · Gilead Sciences, Inc. Completes Acquisition of YM BioSciences - read this article along with other careers information, tips and advice on BioSpace
ASCO '11: YM BioSciences Attracts Wall Street - TheStreet Jun 04, 2011 · CHICAGO ( TheStreet) -- YM BioSciences ()was the beneficiary of the first Wall Street scrum of ASCO 2011 Friday afternoon. Dozens of investors and analysts jockeyed for position around a Gilead to Buy YM BioSciences - Business Finance, Stock ... Dec 13, 2012 · In a bid to expand its oncology pipeline, biopharmaceutical company Gilead Sciences Inc. inked a definitive agreement to buy a Canada-based drug development company, YM … YM.TO Interactive Stock Chart | YM Biosciences, Inc. Stock ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. IGMS Interactive Stock Chart | IGM Biosciences, Inc. Stock ...